Predisposing factors and prognosis of status epilepticus in patients with autoimmune encephalitis

被引:12
|
作者
Zhang, Yu [1 ,2 ]
Deng, Chen [1 ]
Zhu, Lina [1 ]
Ling, Liu [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Neurol, Wai Nan Guo Xue Lane 37, Chengdu 610041, Sichuan, Peoples R China
[2] Chengdu Shangjin Nanfu Hosp, Dept Neurol, Chengdu, Sichuan, Peoples R China
关键词
autoimmune encephalitis; prognosis; status epilepticus; GLUTAMIC-ACID DECARBOXYLASE; DIAGNOSIS; ANTIBODIES;
D O I
10.1097/MD.0000000000019601
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to study the predisposing factors and prognosis of status epilepticus (SE) in patients with autoimmune encephalitis (AE). A total of 227 cases of AE were collected from the inpatient department of West China Hospital of Sichuan University from January 2010 to May 2018. All patients met the 2015 criteria for the diagnosis of AE. The binary logistic regression model was used to multivariate and retrospective chart analysis the predisposition factors for SE and its prognostic factors. Of the 227 patients with AE, 50 (22.03%) had SE during hospitalization, and 19 patients with SE had a poor prognosis (modified Rankin score MRS = 3-6), and 7 patients with no SE had a poor prognosis. In the logistic regression model, electroencephalograms (EEGs) abnormalities (P = .000) and head magnetic resonance imaging (MRI) abnormalities (P = .003) were associated with a predisposition to SE, while Glasgow scores <8 (P = .027), abnormal EEG (P = .046), delayed immunotherapy (P = .012), and SE duration at admission lasting >30 minutes (P = .023) were risk factors for a poor prognosis of SE. SE is a common complication in patients with AE. EEG and MRI abnormalities may be predisposing factors for SE. Glasgow scores <8 points, abnormal EEG, delayed immunotherapy, and SE duration lasting >30 minutes at admission are risk factors for a poor prognosis in patients with SE.
引用
收藏
页数:5
相关论文
共 50 条
  • [11] Prognosis of status epilepticus in elderly patients
    Vilella, L.
    Gonzalez Cuevas, M.
    Quintana Luque, M.
    Toledo, M.
    Sueiras Gil, M.
    Guzman, L.
    Salas Puig, J.
    Santamarina Perez, E.
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 137 (03): : 321 - 328
  • [12] PROGNOSIS OF STATUS EPILEPTICUS IN ELDERLY PATIENTS
    Vilella, L.
    Abraira, L.
    Santamarina, E.
    Gonzalez Cuevas, M.
    Quintana, M.
    Toledo, M.
    Sueiras, M.
    Guzman, L.
    Garcia-Tornel Garcia-Camba, A.
    Vila, C.
    Salas Puig, X.
    EPILEPSIA, 2016, 57 : 203 - 203
  • [13] Refractory status epilepticus: risk factors and prognosis
    Meierkord, H
    Othman, J
    Buchheim, K
    Holtkamp, M
    EPILEPSIA, 2004, 45 : 65 - 66
  • [14] Analysis of risk factors for a poor functional prognosis and relapse in patients with autoimmune encephalitis
    Yao, Yu
    Zhang, Ou
    Gu, Lijun
    Zhang, Xu
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 369
  • [15] Factors in the development of refractory status epilepticus in status epilepticus patients
    Sahin, Oruc
    Gunes, Muzaffer
    EPILEPSY & BEHAVIOR, 2025, 163
  • [16] Autoimmune Status Epilepticus
    LoPinto-Khoury, Carla
    Sperling, Michael R.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2013, 15 (05) : 545 - 556
  • [17] Autoimmune Status Epilepticus
    Carla LoPinto-Khoury
    Michael R. Sperling
    Current Treatment Options in Neurology, 2013, 15 : 545 - 556
  • [18] Autoimmune status epilepticus
    Langenbruch, Lisa
    Kovac, Stjepana
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2020, 33 (04): : 306 - 309
  • [19] The Diagnostic Challenge of Seronegative Autoimmune Encephalitis With Super-Refractory Status Epilepticus
    Vadagandla, Koti
    Jahagirdar, Vinay
    Rama, Kaanthi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (11)
  • [20] ANTECEDENTS, PRECIPITANTS, AND PROGNOSIS OF PATIENTS WITH STATUS EPILEPTICUS
    BARRY, E
    HAUSER, WA
    EPILEPSIA, 1983, 24 (04) : 519 - 520